Open access
Oct 2026
Emerging antibody-drug conjugate (ADC) therapies: perspectives from the global patent landscape
Antibody-drug conjugates (ADCs) represent one of the most significant innovations in biopharmaceutical research, integrating antibody target specificity with the cytotoxic potency of small-molecule payloads. Despite rapid progress, the technological structure and knowledge dynamics underlying ADC innovation remain...
Tong Wu, Bai-Jun Liu, Jia-Yu Jin et al.
· Frontiers in Pharmacology · 0 citations